Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Still River is a classic venture capital organization seeking to make investments in dynamic growing companies who have created cutting edge products or services that have the potential to play a dominant role in the industry they serve. Most investments that the fund makes will be in private companies located in the northeast United States and doing business in the telecommunications, e-commerce, life sciences, and business services industries.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
1/2001 | Stargus | Venture Round | 0 |
12/2006 | Xanthus Pharmaceuticals | Series B | 0 |
11/1999 | NewMediary | Series B | 5M |
12/2003 | Xanthus Pharmaceuticals | Series B | 0 |
2/2003 | Xanthus Pharmaceuticals | Series A | 0 |
4/2000 | HookMedia | Series B | 0 |
1/2007 | MEMSIC | Series D | 8.4M |
12/2009 | Contour Semiconductor | Venture Round | 8M |
9/2005 | Xelor Software | Series B | 6M |
10/2001 | Global Communication Devices | Series B | 15.6M |
3/2000 | Content Integrity | Series A | 3M |
5/2001 | MEMSIC | Series B | 8.3M |
1/2000 | Broadband Access Systems | Venture Round | 44.3M |
1/1999 | HookMedia | Series A | - |
10/2000 | MEMSIC | Series A | 2M |
8/2000 | Global Communication Devices | Series A | - |
12/2009 | Contour Semiconductor | Venture Round | 0 |
1/2007 | MEMSIC | Series D | 0 |
12/2006 | Xanthus Pharmaceuticals | Series B | 0 |
9/2005 | Xelor Software | Series B | 0 |
12/2003 | Xanthus Pharmaceuticals | Series B | 0 |
2/2003 | Xanthus Pharmaceuticals | Series A | 0 |
10/2001 | Global Communication Devices | Series B | 0 |
5/2001 | MEMSIC | Series B | 0 |
1/2001 | Stargus | Venture Round | 0 |
10/2000 | MEMSIC | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|